Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction
US6953800B2 · kind B2 · utility
11Cited by
4References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 22, 2001 |
| Grant date | Oct 11, 2005 |
| Priority date | — |
| Expiry date | Dec 16, 2021 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described is the use in the treatment of either male or female sexual dysfunction of selective antagonists of the α1B-adrenergic receptor and the pharmaceutical compositions containing them as compounds capable of helping the sexual act avoiding at the same time excessive side effects due to acute hypotension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.